Home » Topics » Regulatory

Regulatory
RSS

FDA grants priority review status to etanercept for treatment of psoriatic arthritis

Sep. 19, 2001

Adapalene and pharmaceutical compositions thereof for use in cancer therapy

Sep. 17, 2001

Pump therapy with insulin aspart approved by EMEA

Sep. 14, 2001

Plavix sNDA granted FDA priority review

Sep. 13, 2001

Allergan's Botox cleared in Canada for treatment of axillary hyperhidrosis

Sep. 13, 2001

FDA approves Xeloda/Taxotere combination therapy for metastatic breast cancer

Sep. 13, 2001

Further submissions announced for Visudyne

Sep. 13, 2001

Novartis, QLT seek approval for expanded use of Visudyne in E.U.

Sep. 12, 2001

Janssen seeks FDA approval of new long-acting Risperdal formulation

Sep. 10, 2001

Ortec's OrCel approved for healing donor site wounds in burn victims

Sep. 10, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...